Literature DB >> 28574774

Differing Experiences with Pre-Exposure Prophylaxis in Boston Among Lesbian, Gay, Bisexual, and Transgender Specialists and Generalists in Primary Care: Implications for Scale-Up.

Douglas S Krakower1,2, Norma C Ware3, Kevin M Maloney1, Ira B Wilson4, John B Wong5, Kenneth H Mayer1,2.   

Abstract

The Centers for Disease Control and Prevention estimates that one in four sexually active men who have sex with men (MSM) could decrease their HIV risk by using HIV pre-exposure prophylaxis (PrEP). Because many MSM access healthcare from primary care providers (PCPs), these clinicians could play an important role in providing access to PrEP. Semistructured qualitative interviews were conducted with 31 PCPs in Boston, MA, to explore how they approach decisions about prescribing PrEP to MSM and their experiences with PrEP provision. Purposive sampling included 12 PCPs from an urban community health center specializing in the care of lesbian, gay, bisexual, and transgender persons ("LGBT specialists") and 19 PCPs from a general academic medical center ("generalists"). Analyses utilized an inductive approach to identify emergent themes. Both groups of PCPs approached prescribing decisions about PrEP as a process of informed decision-making with patients. Providers would defer to patients' preferences if they were unsure about the appropriateness of PrEP. LGBT specialists and generalists were at vastly different stages of adopting PrEP into practice. For LGBT specialists, PrEP was a disruptive innovation that rapidly became normative in practice. Generalists had limited experience with PrEP; however, they desired succinct decision-support tools to help them achieve proficiency, because they considered preventive medicine to be central to their professional role. As generalists vastly outnumber LGBT specialists in the United States, interventions to support PrEP provision by generalists could accelerate the scale-up of PrEP for MSM nationally, which could in turn decrease HIV incidence for this priority population.

Entities:  

Keywords:  HIV; men who have sex with men; pre-exposure prophylaxis; primary care providers; qualitative research

Mesh:

Substances:

Year:  2017        PMID: 28574774      PMCID: PMC5512323          DOI: 10.1089/apc.2017.0031

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  38 in total

1.  PrEP Continuum of Care for MSM in Atlanta and Los Angeles County.

Authors:  Dvora Joseph Davey; Maria Jose Bustamante; Daidong Wang; Sean Young; Jeffrey David Klausner
Journal:  Clin Infect Dis       Date:  2015-10-20       Impact factor: 9.079

2.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

3.  The coming golden age of disruptive innovation in health care.

Authors:  Eyal Zimlichman; Jeffrey Levin-Scherz
Journal:  J Gen Intern Med       Date:  2013-07       Impact factor: 5.128

4.  A Clinical Home for Preexposure Prophylaxis: Diverse Health Care Providers' Perspectives on the "Purview Paradox".

Authors:  Susie Hoffman; John A Guidry; Kate L Collier; Joanne E Mantell; Daria Boccher-Lattimore; Farnaz Kaighobadi; Theo G M Sandfort
Journal:  J Int Assoc Provid AIDS Care       Date:  2015-08-20

5.  State-level structural sexual stigma and HIV prevention in a national online sample of HIV-uninfected MSM in the United States.

Authors:  Catherine E Oldenburg; Amaya G Perez-Brumer; Mark L Hatzenbuehler; Douglas Krakower; David S Novak; Matthew J Mimiaga; Kenneth H Mayer
Journal:  AIDS       Date:  2015-04-24       Impact factor: 4.177

6.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

7.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

8.  HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.

Authors:  Douglas Krakower; Norma Ware; Jennifer A Mitty; Kevin Maloney; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2014-09

Review 9.  Ten Years, Forty Decision Aids, And Thousands Of Patient Uses: Shared Decision Making At Massachusetts General Hospital.

Authors:  Karen R Sepucha; Leigh H Simmons; Michael J Barry; Susan Edgman-Levitan; Adam M Licurse; Sreekanth K Chaguturu
Journal:  Health Aff (Millwood)       Date:  2016-04       Impact factor: 6.301

10.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Authors:  Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill
Journal:  Lancet       Date:  2015-09-09       Impact factor: 79.321

View more
  24 in total

Review 1.  Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States.

Authors:  Kenneth H Mayer; Philip A Chan; Rupa R Patel; Charlene A Flash; Douglas S Krakower
Journal:  J Acquir Immune Defic Syndr       Date:  2018-02-01       Impact factor: 3.731

2.  Decisional Balance and Contemplation Ladder to Support Interventions for HIV Pre-Exposure Prophylaxis Uptake and Persistence.

Authors:  Steven A John; H Jonathon Rendina; Tyrel J Starks; Christian Grov; Jeffrey T Parsons
Journal:  AIDS Patient Care STDS       Date:  2019-01-17       Impact factor: 5.078

3.  Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers.

Authors:  Sarah K Calabrese; Mehrit Tekeste; Kenneth H Mayer; Manya Magnus; Douglas S Krakower; Trace S Kershaw; Adam I Eldahan; Lauren A Gaston Hawkins; Kristen Underhill; Nathan B Hansen; Joseph R Betancourt; John F Dovidio
Journal:  AIDS Patient Care STDS       Date:  2019-02       Impact factor: 5.078

4.  Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.

Authors:  Christina J Sun; Kirsten M Anderson; David Bangsberg; Kim Toevs; Dayna Morrison; Caitlin Wells; Pete Clark; Christina Nicolaidis
Journal:  J Gen Intern Med       Date:  2019-02-04       Impact factor: 5.128

5.  HIV Post-Exposure Prophylaxis (PEP) Awareness and Non-Occupational PEP (nPEP) Prescribing History Among U.S. Healthcare Providers.

Authors:  Steven A John; Katherine G Quinn; Benedikt Pleuhs; Jennifer L Walsh; Andrew E Petroll
Journal:  AIDS Behav       Date:  2020-11

6.  Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.

Authors:  Benedikt Pleuhs; Katherine G Quinn; Jennifer L Walsh; Andrew E Petroll; Steven A John
Journal:  AIDS Patient Care STDS       Date:  2020-02-28       Impact factor: 5.078

7.  Human Immunodeficiency Virus/Sexually Transmitted Infection Counseling and Testing Services Received by Gay and Bisexual Men Using Preexposure Prophylaxis at Their Last PrEP Care Visit.

Authors:  Jeffrey T Parsons; Steven A John; Thomas H F Whitfield; Jorge Cienfuegos-Szalay; Christian Grov
Journal:  Sex Transm Dis       Date:  2018-12       Impact factor: 2.830

8.  HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis.

Authors:  Chen Zhang; James McMahon; Kevin Fiscella; Sarahmona Przybyla; Amy Braksmajer; Natalie LeBlanc; Yu Liu
Journal:  AIDS Patient Care STDS       Date:  2019-12       Impact factor: 5.078

9.  Awareness and Interest in HIV Pre-Exposure Prophylaxis Among Street-Based Female Sex Workers: Results from a US Context.

Authors:  Catherine Tomko; Ju Nyeong Park; Sean T Allen; Jennifer Glick; Noya Galai; Michele R Decker; Katherine H A Footer; Susan G Sherman
Journal:  AIDS Patient Care STDS       Date:  2019-01-11       Impact factor: 5.078

10.  Missed Opportunities to Prescribe HIV Pre-Exposure Prophylaxis by Primary Care Providers in Saint Louis, Missouri.

Authors:  Rupa R Patel; Philip A Chan; Laura C Harrison; Kenneth H Mayer; Amy Nunn; Leandro A Mena; William G Powderly
Journal:  LGBT Health       Date:  2018-04-24       Impact factor: 4.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.